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The development of new imaging tools, molecules and modalities is crucial to understanding biological
processes and the localised cellular impact of bioactive compounds. A small molecule photosensitiser,
DC473, has been designed to be both highly ﬂuorescent and to exhibit a strong Raman signal in the cell-
silent region of the Raman spectrum due to a diphenylacetylene structure. DC473 has been utilised to
perform a range of novel tandem ﬂuorescence and Raman (ﬂuoRaman) imaging experiments, enabling a
thorough examination of the compound’s cellular localisation, exempliﬁed in colorectal cancer cells
(SW480). This multifunctional ﬂuoRaman imaging modality revealed the presence of the compound in
lipid droplets and only a weak signal in the cytosol, by both Raman and ﬂuorescence imaging. In addition,
Raman microscopy detected the compound in a cell compartment we labelled as the nucleolus, whereas
ﬂuorescence microscopy did not detect the ﬂuoRaman probe due to solvatochromatic eﬀects in a
local polar environment. This last ﬁnding was only possible with the use of tandem confocal Raman and
ﬂuorescence methods. By following the approach detailed herein, incorporation of strong Raman func-
tional groups into ﬂuorophores can enable a plethora of ﬂuoRaman experiments, shedding further light
on potential drug compound’s cellular behaviour and biological activity.
Introduction
Imaging and tracing bioactive compounds in vivo is essential
to understanding their mechanism of action. However, tagging
them while retaining their inherent biological activity and
function is very diﬃcult, in particular when large fluorescent
molecules such as the 238 residue Green Fluorescent Protein
(GFP) are employed as labels.1 An inherently fluorescent bio-
active molecule that does not require labelling is, therefore,
highly desirable. However, there are other issues to consider
when using fluorescence for quantitative molecular tracking,
including photobleaching during the experiment,1 solvato-
chromatic or fluorogenic eﬀects in diﬀerent locations within
the cell and non-linear responses from the fluorophore due to
localised concentrations or self-absorption.2 For this reason,
novel and complementary techniques for the detection and
characterisation of a bioactive molecule within a cellular
environment are needed.
Raman spectroscopy uses the inelastic scattering of mono-
chromatic light to provide information on the vibrational
modes of a sample, allowing the detection of chemical func-
tional groups.3 It is a label-free and non-destructive technique,
with the ability to diagnose disease states or track the bio-
chemical changes occurring in a cell over time.4 Raman
spectroscopy can be a valuable tool, not only for imaging a
compound within a cell in a semi-quantitative manner, but
also for obtaining information on the molecules with which
they co-locate.5 However, Raman signal intensity is several
orders of magnitude weaker than fluorescence or elastic
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scattering signals making the technique inherently slow and
hence, lacking in suﬃcient sensitivity.4
To overcome these drawbacks, and to obtain orthogonal
information provided by Raman measurements, multimodal
imaging systems can be used.4 Fluorescence is usually a
problem in Raman spectroscopy, as it can cause significant
background signal. Much eﬀort has, therefore, gone into the
design of Raman systems to reduce interference from fluo-
rescence.4 Since 2003, several groups have adopted the multi-
modal approach for increasing the tissue-diagnosis sensitivity
of Raman probes by combining Raman with tissue auto-fluo-
rescence.4,6,7 Fluorescence tends to be used either as a confir-
matory technique for the Raman mapping, or as a quick
mapping technique to choose the areas of interest prior to
Raman imaging in a large sample.4 Some researchers have
used both techniques in a complementary manner, such as
the work of Carney et al. on extracellular vesicles using laser
tweezers Raman spectroscopy and fluorescence labelling with
CD9+ antibodies.8 Raman and fluorescence have also been
shown to provide complementary information for studying pH
eﬀects of doxorubicin uptake,9 for tissue imaging using
surface-enhanced Raman scattering (SERS) and fluorescence
based endoscopy10 and for dual drug release studies, using
both surface-enhanced resonance Raman scattering (SERRS)
and energy transfer to probe length scales.11 Other groups that
have combined fluorescence and Raman include Zeng et al.
who tracked autofluorescence lifetime and stimulated Raman
scattering of naturally occurring lignin molecules in poplar
cells,12 Manen et al. tracked both the resonant Raman signal
of flavocytochrome b558 and the fluorescence of labelled
quantum dots in single live neutrophils using the same exci-
tation laser,13 and Uzunbajakava et al. investigated DNA using
spontaneous Raman and two-photon excited fluorescence of the
DNA dye Hoechst 33342.14 Designing a molecular probe that
can be imaged by both tandem fluorescence and Raman scatter-
ing could give additional information in the location and
environment of the probe. Following this approach, Li et al.
designed a mitochondrial probe for both stimulated Raman
scattering (SRS) and aggregation induced emission (AIE) fluo-
rescence in HeLa cells.15 However, to our knowledge, designing
a potential chemotherapeutic compound that can be imaged by
both fluorescence and specific spontaneous Raman scattering
(RS) in tandem (fluoRaman) has not been shown previously.
The vibrational signals associated with chemotherapeutic
drugs often occur within the so-called “fingerprint” region of
the spectrum, that also contains the vibrational information of
both cells and tissue.16 Consequently, the reliable and confi-
dent analysis of drug distribution in cells can be extremely
challenging. Designing bioactive compounds with Raman sig-
natures in the cell-silent region between 1800–2800 cm−1 can
enable detection of the compound more accurately in cellular
samples.17 Alkynes are one such example, and typically
exhibit a vibrational frequency of ca. 2125 cm−1 with intrinsi-
cally sharp peaks (fwhm ∼14 cm−1).18 Alkyne labels for Raman
spectroscopy were introduced in the last decade by Yamakoshi
et al.19,20 and alkyne palettes have been developed by Chen
et al. using C13 and C12 isotope combinations18 and by Hu
et al. with their, so called, Carbow.21 These probes show sig-
nificant potential for diagnostic purposes in cancer therapy,
using Raman spectroscopy.
Colorectal cancer (CRC) is the third most common cancer
worldwide, with 1.4 million new cases diagnosed in 2012, with
numbers worldwide predicted to rise to 1.36 million for men
and 1.08 million for women by 2035.22 Around 50% of the
patients develop metastasis to the liver23 and resistance to
standard chemotherapy.24 Novel therapies for the treatment of
CRC are, therefore, needed.
Photodynamic therapy utilises photosensitisers to induce
the production of large quantities of reactive oxygen species
(ROS) for the targeted destruction of diseased tissues, and has
been used to treat a variety of cancers.25 However, current
photosensitisers approved for therapeutic use suﬀer from a
wide variety of issues, including poor pharmacokinetic pro-
perties due to their high molecular weight, often porphyrin
structures, and ineﬀective targeting leading to the death of
healthy tissue.25–27 We have developed a new low molecular
weight, small photosensitiser, DC473 (Fig. 1A), that elicits cell
death through the stimulated production of ROS when acti-
vated by UV-A, violet or corresponding near-infrared two-
photon wavelengths.28 To improve this photosensitising
activity, a precise understanding of the compound’s cellular
localisation is necessary. DC473 exhibits strong solvatochro-
matic fluorescence and possesses two alkynes suitable for
Raman spectroscopy. It was anticipated that this unique com-
bination of structural and photophysical properties would
enable a range of novel tandem fluorescence and Raman
(fluoRaman) imaging methodologies and experiments.
Indeed, herein we report a detailed investigation into the cellu-
lar localisation of DC473 in the SW480 CRC cell line using
confocal fluorescence and Raman (fluoRaman) microscopy,
proving co-location of the compound signal with both tech-
niques, and obtain the Raman signature of the organelles with
which it spatially correlates.
Materials and methods
General photophysical information
UV-visible absorption spectra were obtained on an Agilent
1100 Series Diode Array spectrophotometer using standard
1 cm path length quartz cells. Excitation and emission spectra
were recorded on an Edinburgh Instruments FLSP920 spectro-
photometer, equipped with a 450 W xenon arc lamp, double
monochromators for the excitation and emission pathways,
and a red sensitive photomultiplier (PMT-R928) and a near-IR
PMT as detectors, or on a Horiba Jobin–Yvon Fluoromax 3
spectrophotometer with single monochromators for the exci-
tation and emission pathways. The excitation and emission
spectra were corrected using the standard corrections supplied
by the manufacturers for the spectral power of the excitation
source and the sensitivity of the detector. The quantum yields
were measured by use of integrating spheres with either the
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Edinburgh Instruments FLSP920 spectrophotometer or the
Horiba Jobin–Yvon Fluoromax 3 spectrophotometer. The
luminescence lifetimes were measured using a TCSPC module
on an FLSP980 spectrometer equipped with a high-speed
photomultiplier tube positioned after a single emission mono-
chromator and operating with pulsed laser diodes (376 or
274 nm, repetition rate 1–5 MHz, pulse width ca. 200 ps,
instrument response function ca. 500 ps). Decays were
recorded to 104 counts in the peak channel with a record
length of at least 1000 channels. The band-pass of the mono-
chromator was adjusted to give a signal count rate of <20 kHz.
Iterative deconvolution of the IRF with one decay function and
nonlinear least-squares analysis were used to analyse the data.
The quality of all decay fits was judged to be satisfactory,
based on the calculated values of the reduced X2 and Durbin-
Watson parameters and visual inspection of the weighted and
autocorrelated residuals.
Cell culture
SW480 cells were provided by Dr N. West from Saint James’s
University Hospital and were cultured in Dulbecco’s modified
Eagle medium (DMEM, Gibco) supplemented with 10% fetal
bovine serum (Sigma), 2 mM glutamax (Thermo Fisher
Scientific) and penicillin 100 units per mL streptomycin
100 µg mL−1 (Sigma). All experiments were done with passage
numbers below 50. Quartz slides (UQG Optics, 75 × 25 ×
1 mm) and coverslips (25.4 × 25.4 × 0.15–0.25 mm Alfa Aesar)
were sonicated with acetone (VWR Chemicals), 2–5% decon 90
(VWR Chemicals) and rinsed with milliQ. Hydrogen peroxide
30% (Thermo Fisher) and sulphuric acid >95% (Thermo
Fisher) were mixed in a 3 : 7 proportion (Piranha solution) and
used to clean the slides for 20 minutes. Slides and coverslips
were rinsed and stored in milliQ and dried under a stream of
nitrogen immediately before using. Quartz coverslips were
coated with poly-L-Lys (Sigma) and basement membrane
extract (BME, Cultrex) to increase cell adherence. Treatment
with poly-L-lysine was done covering the coverslip with 10 µg
mL−1 poly-L-lysine solution and incubating for 1 h, storing at
4 °C for 1 week. BME 12–18 mg mL−1 was thawed and diluted
to ∼150 µg mL−1. Coverslips were rinsed with DPBS and BME
was added and incubated for 1 h. Cells (viability 96% Trypan
blue) were seeded at a concentration of 3.5 × 105 cells per well
2 days in advance. After two days, cells were treated with either
DC473 4 µM or the equivalent volume of dimethyl sulfoxide
(DMSO, sterile, New England Biolabs) in complete DMEM for
4 hours. After incubation, cells were washed with DPBS and
Fig. 1 A. Chemical structure and summary of the properties of photosensitiser, DC473. B. Raman spectrum of DC473, in the solid state, taken with
the 40× and 785 nm laser excitation; the inset shows the CuC band. The Raman signals corresponding to the alkyne and phenyl groups are
indicated in red and blue on the peak labels, respectively. The main Raman bands tracked in this study are the 1597 cm−1 phenyl CvC stretch
and the 2197 cm−1 CuC stretch vibrations. C. Absorption and D. emission spectra of DC473 in a variety of solvents MeCy = methylcyclohexane,
Tol = toluene and DCM = CH2Cl2.
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fixed with 4% paraformaldehyde (PFA, Sigma Aldrich) for
10 min. Spacers were prepared using a 50 µm polyethylene
terephthalate film (Goodfellow, UK). Cells were measured
immediately by bonding the coverslip to a quartz slide, creat-
ing a small chamber with the spacers, and sealing the setup
with wax to minimize evaporation.
Confocal Raman spectroscopy and fluorescence
The Raman system used was an inVia Raman confocal inverted
microscope (Renishaw) integrated with a Leica DMi8/SP8 laser
scanning confocal microscope system. Raman excitation lasers
were a 785 nm diode laser (laser power of 45 mW at the
sample, intensity of ∼5.7 MW cm−2) and a 532 nm laser (laser
power of 22 mW on the sample, intensity of ∼2.7 MW cm−2)
and a 1200 l mm−1 and 1800 l mm−1 grating for each laser,
respectively. Light was collected using a near infrared
enhanced CCD array detector (1024 × 256 pixels). Prior to every
experiment a spectrum of a silicon sample was collected and
the microscope was calibrated to the peak position
(520.5 cm−1). The cell spectra were obtained using a 100× oil
immersion objective (HC PL APO CS2 FWD 0.13 mm NA 1.4)
with a slit size of 20 µm. This setting gave an axial resolution
(full width half maximum) of 1.7 µm when Z-scanning from a
silicon sample and tracking the 520.5 cm−1 peak. For the indi-
vidual spectra taken with the 785 nm laser, the exposure time
was 1 s with 15 accumulations. For the individual spectra
taken with the 532 nm laser exposure time was 1 s with 10
accumulations. For the mapping with the 785 nm laser the
step size was 0.7–1 µm and exposure time was 1.8–2 s px−1.
Confocal fluorescence imaging used excitation at 405 nm and
collected emission in the range 432–543 nm with Pinhole size
of 1 Airy disc.
Pre-processing and statistical errors
Preprocessing. The spectra obtained were cosmic ray filtered
(WiRE® software) and exported as text files for further analysis
with in-house built scripts using the Matlab’s Statistics and
Machine Learning Toolbox (MathWorks). The Matlab func-
tions used are indicated in italics. The silicon peak of a cali-
bration sample was used to calibrate the wavenumber axis of
each spectrum. The spectra were gently baseline corrected
using the algorithm developed by Koch et al. (2016)29 with
smooth-width of 100, band-width of 600 and 5 iterations, and
normalized to the Amide I peak. Statistical errors. Unless
stated otherwise, all values are expressed ± the standard error
calculated as σ/√N, where σ is the standard deviation and N
the sample size. Raman maps. For all Raman images, contrast
was adjusted with the percentile of the data of all pixels from
all the maps used using a LUT of 1–99% – where 1% of pixels
intensity is saturated at either end of the colour map.
A Gaussian filter with radius size of half a pixel was used to
smooth the pixel structure of the false colour images. Intensity
images. Indicated peaks were integrated to the baseline for
each of the individual spectra using appropriate peak width,
obtaining the integrated intensity. Principal Component
Analysis (PCA). The edited data was standardized using
Standard Normal Variate and the function pca was used,
where the PCs obtained were plotted without any additional
normalization. The scores of each pixel were plotted as
images.
Results and discussion
Synthesis, photophysical properties and Raman
characterisation
The photophysical behaviour of diphenylacetylene (tolan) has
been widely studied, and the compound’s conjugated structure
has been extensively modified to tailor its properties towards a
variety of applictions.30–39 By appending strong π-donor (e.g.
NR2) and π-acceptor (e.g. CO2H, CO2R) moieties, the absorp-
tion and emission characteristics of these compounds can be
significantly bathochromically shifted due to the formation of
intramolecular charge transfer (ICT) excited states.40,41
Diphenylacetylenes are also known to exhibit triple bond
stretching vibrations of particularly strong intensity in Raman
spectroscopy in comparison to other alkynes.20 Thus, dipheny-
lacetylenes potentially represent an ideal structural class for
use in fluoRaman imaging.
For this purpose, we designed and synthesised DC473
(Fig. 1A), a substituted diphenylacetylene with a highly lipophi-
lic, electron rich tetrahydroquinoline donor and a methyl cin-
namate acceptor (for organic synthetic procedures, see ESI†).42
The compound exhibits two strong absorption bands in the
UV and violet regions, and a highly solvatochromatic fluo-
rescence emission with quantum yields up to 1.0 in non-polar
solvents (Fig. 1C and D and Table 1). In non-polar solvents,
DC473 exhibits strong emission in the blue/green region,
while in more polar solvents the emission is significantly bath-
ochromically shifted due to stabilisation of the intramolecular
charge transfer excited state. The emission is also much
weaker in polar solvents such as EtOH. Accordingly, in a cellu-
lar context, fluorescence microscopy indicated that DC473 is
clearly present in non-polar, membrane-rich environments.
However, while the compound was not visible in the cytosol by
fluorescence, it would be unwise to infer that the compound
was completely absent from this environment.
Hence, we pursued the complementary use of Raman spec-
troscopy, in tandem with fluorescence, to fully understand and
characterise the compound’s cellular localisation. Fig. 1B
shows the Raman spectrum of DC473 acquired with a 785 nm
Table 1 Photophysical properties of DC473 in a variety of solvents,
where λ is the wavelength, ϕ is the quantum yield and τ is the ﬂuor-
escence lifetime
Solvent λabs(max)/nm (ε/m
−1 cm−1) λem(max)/nm ϕ τ/ns
MeCy — 414, 437 — —
Toluene 378 (33 200), 292 (24 900) 468 1.00 1.6
EtOH 375, 294 569 0.01 —
CH2Cl2 — 567 — —
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laser after baseline subtraction, with the characteristic presence
of the diphenylacetylene triple bond stretching vibration at
2197 cm−1. Alkyne peaks usually appear at ca. 2125 cm−1;18
however, the electron-rich tetrahydroquinoline donor group
causes a shift to 2197 cm−1.21 N-Propargyl alkynes Raman
bands are typically much less intense and of lower wavenumber
than their diphenylacetylene counterparts and it is, therefore,
likely that this alkyne stretch is present as one of the weaker
signals in the 2080–2160 cm−1 region. A strong signal assigned
as phenyl ring vibrations was also evident at 1597 cm−1. Both
the phenyl vibrations at 1597 cm−1 and the 2197 cm−1 diphenyl-
acetylene alkyne peak were used for the detection of the com-
pound via Raman spectroscopy in single cells.
Cellular imaging
With the fluorescence and Raman signatures of DC473 under-
stood, we next sought to characterise the compound’s cellular
localisation and behaviour using the primary adenocarcinoma
colorectal cancer cell line, SW480. First, the Raman spectra
were acquired with a 785 nm laser at individual points in fixed
SW480 cells that had been incubated with DC473, and com-
pared with the confocal fluorescence images of the same cells.
Fig. 2C shows high-quality raw Raman spectra taken from
diﬀerent parts of a fixed cell. DC473 accumulation was
detected when measuring in vesicles and in membranes, but
not in the nucleus. The fluorescence image in Fig. 2B shows
accumulation of the compound mainly in vesicles and weakly
in the cytosol, but not in the nucleus. Raman measurements
in the indicated points (V1–3) confirmed the presence of
DC473 in particles which correlate with the strong 1455 cm−1
band associated with lipids, indicating that they were likely
lipid droplets, previously described in this cell line.43,44
Cytosol measurements showed weak signals of DC473, in
agreement with the fluorescence characterisation. Single point
measurements in the nucleus showed only a very weak signal
from the compound.
When exciting with the 532 nm laser, cytochrome c, a
small, soluble heme-protein localised in mitochondria, shows
a resonant Raman signal.45,46 Fig. 2D and E show the bright
field and confocal fluorescence images of an SW480 cell fol-
lowing incubation with DC473. Fig. 2F shows individual points
probed with RS with a 532 nm laser in the same cell in vesi-
cles, the nucleus, cytosol and filopodia. Similar to the results
obtained with the near-infrared excitation, DC473 was detected
strongly in vesicles and weakly in the cytosol. The cytosol
regions examined exhibited the characteristic 749, 1128, 1310
and 1582 cm−1 cytochrome peaks, indicating that the DC473
in this compartment could be localized near, or inside, the
mitochondria. Mitochondria are an important target for
photodynamic therapy agents and it is, therefore, important to
understand the behaviour of DC473 with respect to co-localis-
ation with the mitochondria signal. Ideally, higher resolution
studies should be undertaken to confirm this co-localisation.
However, given the large membranous area associated with the
mitochondria and the ability of DC473 to accumulate in lipid
rich environments, this seems reasonable. Indeed, given that
the DC473 signal is not resonantly enhanced whilst that of the
cytochrome c is, would imply significant accumulations of
DC473 in the mitochondria, perhaps as high as 3–4 orders of
magnitude greater than that of cytochrome c.
Fig. 2 A and D Show the bright ﬁeld and B and E show the confocal ﬂuorescence images of ﬁxed SW480 cells following incubation with DC473
whose point spectra were measured in C and F, respectively, where V stands for vesicle, N for nucleus, F for ﬁlopodia and C for cytosol. C. Raw
Raman 785 nm spectra at selected points of the SW480 cell showed in A and B. The green bands show the main peaks associated with the presence
of the compound in diﬀerent cellular locations, with strong presence in vesicles. F. 532 nm Raman baseline subtracted spectrum of selected points
of the SW480 cell showed in D and E. The green bands show the main DC473 peaks, showing a similar trend to Fig. 1B. Measurements in the cytosol
show weak signal of DC473 and resonant Raman bands of cytochrome c, indicated with red bands.
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Mapping of DC473 accumulation using confocal fluorescence
and Raman spectroscopy
Raman mapping was undertaken on fixed SW480 cells incu-
bated with the compound, or with an equivalent concentration
of DMSO, as a control (Fig. 3) using 785 nm excitation. This
excitation was chosen due to a small but non-zero overlap of
the fluorescence excitation spectrum of the molecule with the
532 nm excitation line. Bright field and fluorescence images
for the DC473-treated cell are shown together with the Raman
maps associated with the main spectral peaks. The 1338 cm−1
band, usually assigned as a mixed contribution of CH2
wagging, C–O stretching, phenyl stretching and N–H
deformation,47–49 appears most strongly here in the nucleus.
Fig. 3 Peak integrated intensity maps for SW480 ﬁxed cells either incubated with DC473 or with an equivalent concentration of DMSO as a
control. The 1597 and 2197 cm−1 peaks show DC473 accumulation mainly in lipid droplets, as indicated by the correlation with the 1445 cm−1 inten-
sity map mainly due to lipid vibrations. The 1338 cm−1 intensity map shows mixed contributions of proteins and nucleic acids, and the 1656 cm−1
map shows Amide I intensity as a map of proteins. The 1455 and 1434 cm−1 maps mainly show contributions of lipids.
Fig. 4 A. Bright ﬁeld and confocal ﬂuorescence images of the ﬁxed SW480 cell incubated with DC473. The maps of each of the scores of the
4 main PCs are shown. B. Coeﬃcients for the ﬁrst 4 PCs whose scores are mapped in A. C. Bright ﬁeld, ﬂuorescence and score maps of PCA
coeﬃcients with DC473 associated Raman bands. The cell main features have been overlaid with the images as a visual aid. The presence of PC4
suggests that Raman could be detecting presence of DC473 in a region in the nucleus that does not show in the ﬂuorescence image.
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The 1434 cm−1 band associated with methylene stretching50,51
shows a strong contribution in lipid droplets rich regions and
exhibits a strong correlation with the 1455 cm−1 band associated
with lipids and fatty acids50 as well as the 1597 cm−1 phenyl
peak associated with DC473. The 1656 cm−1 Amide I band50
due to proteins is evident over the whole cell area. The two main
DC473 peaks, 1597 cm−1 (phenyl) and 2197 cm−1 (alkyne), show
a strong correlation with the lipid peaks and a weaker contri-
bution in the cytosol, indicating localisation of the compound
in lipid-rich environments. Whilst the 1597 cm−1 DC473 peak is
very strong and provides good contrast in the Raman images, its
presence on the side of the Amide I peak makes it diﬃcult to
separate from that of protein. In contrast, the 2197 cm−1 band,
whilst weaker, occurs in the ‘silent’ region of the spectrum
giving unequivocal detection of the compound.
PCA analysis of one of the maps of a cell incubated with
DC473 is shown in Fig. 4A, along with the coeﬃcients of these
components in Fig. 4B. PC1 shows mainly average cell signal
with DC473 contribution, where the whole cell shows higher
scores than the background and thus gives similar information
to the fluorescence image. PC3 peaks in the nucleus, with
negative contributions for both DC473 and the broad lipid band
around 1448 cm−1. Similarly to the intensity maps, PC2 shows
positive contributions for the region around 1338 cm−1. PC2
and PC4 show the main DC473-specific components. PC2 shows
very strong DC473 presence and a positive 1434 cm−1 methylene
band indicating accumulation in the elongated structures in
the region below the nucleus in Fig. 4A/C.
PC4 shares some similarities with PC2, but with lower
DC473 content and with stronger contribution of a band at
1627 cm−1. This component shows the presence of the com-
pound in diﬀerent regions of the cell that do not correlate with
the fluorescence signal, as shown in Fig. 4. The PC4 component
indicates the presence of DC473 in a compact area inside the
nucleus, suggesting that a low concentration of the compound
could be present inside the nucleolus. The absence of fluo-
rescence in this region might be explained by a solvatochromatic
reduction in quantum yield when the compound is localised in a
more polar environment. Hence, the use of fluoRaman
microscopy can not only identify the presence of the compound
in diﬀerent cell compartments but also provide information
about the polarity of the environment of the compound.
Conclusions
A continuing and major requirement in the life sciences is for
small molecules that can be specifically targeted to sites
within cells, which report back on local conditions within the
cell, and can then be externally activated to alter cell activity
using a minimally invasive method, such as light. We have
designed and synthesised a novel photosensitiser, DC473,
which is both fluorescent and Raman active in the silent
region of the spectra and can, therefore, be tracked within the
cell, with the additional advantage of its solvatochromatic fluo-
rescence properties changing due to local conditions. By
exploiting the unique structural and spectroscopic properties
of DC473, we have utilised fluoRaman microscopy to charac-
terise and understand the cellular localisation of the com-
pound in CRC SW480 cells. These novel imaging experiments
have allowed us to detect the compound mainly in lipid dro-
plets and in the cytosol, where it correlates with the resonant
Raman signal of cytochrome C from mitochondria, suggesting
that it could be located in or near this cellular compartment.
Furthermore, we have acquired maps from single SW480 CRC
fixed cells where Raman imaging strongly detects the com-
pound in lipid droplet rich areas and weakly in the cytosol.
However, further analysis using PCA also shows weak signal
for DC473 within the nucleus, suggesting it could also be
present in the nucleolus, where it does not show fluorescence
due to solvatochromatic eﬀects in a more polar environment.
The detection of the compound in the latter, and its polar
characteristic, would not have been possible using either of
the two techniques used here on their own, i.e., a fluoRaman
confocal imaging approach oﬀers a clear advantage for study-
ing this kind of reporter molecules. We anticipate that, by
application of the types of chemical design principles we have
employed herein, combined with the novel fluoRaman
methods, this type of imaging has significant potential in a
host of cellular and tissue imaging contexts. This approach can
likely be readily applied to a range of other imaging probes and
drugs, potentially providing new insights into the cellular
behaviour of not only these compounds, but enabling new and
unexplored molecular probing methods to be developed.
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